|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/137 | |
| A61K 31/4174 | |||
| A61K 8/30 | |||
| A61K 8/49 | |||
| A61Q 17/04 | |||
| A61Q 19/04 | |||
| A61P 35/00 |
| (11) | Patento numeris | 2598129 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11738997.3 |
| Europos patento paraiškos padavimo data | 2011-06-29 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-06-05 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-05-11 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2011/060939 |
| Data | 2011-06-29 |
| (87) | Numeris | WO 2012/001065 |
| Data | 2012-01-05 |
| (30) | Numeris | Data | Šalis |
| 344333 P | 2010-06-30 | US |
| (72) |
BOUVIER, Guy, FR
LEONI, Matthew James, US
GRAEBER, Michael, US
|
| (73) |
Galderma Research & Development,
2400 Route des Colles Les Templiers, 06410 Biot,
FR
|
| (54) | USE OF ALPHA-ADRENERGIC RECEPTOR AGONIST FOR PREVENTING OR TREATING SKIN TUMOR |
| USE OF ALPHA-ADRENERGIC RECEPTOR AGONIST FOR PREVENTING OR TREATING SKIN TUMOR |